NIOSH Pocket Guide to Chemical Hazards

Platinum (soluble salts, as Pt) CAS

RTECS
Synonyms & Trade Names
Synonyms vary depending upon the specific soluble platinum salt.
DOT ID & Guide
Exposure
Limits
NIOSH REL: TWA 0.002 mg/m3
OSHA PEL: TWA 0.002 mg/m3
IDLH 4 mg/m3 (as Pt) Conversion
Physical Description
Appearance and odor vary depending upon the specific soluble platinum salt.
Properties vary depending upon the specific soluble platinum salt.











Incompatibilities & Reactivities
Varies
Measurement Methods
NIOSH 7300, S191 (II-7)
Personal Protection & Sanitation
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet or contaminated
Change: Daily

First Aid (See procedures)
Eye: Irrigate immediately
Skin: Water flush immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
Respirator Recommendations NIOSH/OSHA
Up to 0.05 mg/m3: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode
Up to 0.1 mg/m3: (APF = 50) Any air-purifying, full-facepiece respirator with a high-efficiency particulate filter/(APF = 50) Any self-contained breathing apparatus with a full facepiece/(APF = 50) Any supplied-air respirator with a full facepiece
Up to 4 mg/m3: (APF = 2000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape: (APF = 50) Any air-purifying, full-facepiece respirator with a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus
Exposure Routes inhalation, ingestion, skin and/or eye contact
Symptoms Irritation eyes, nose; cough, dyspnea (breathing difficulty), wheezing, cyanosis; dermatitis, sensitization skin; lymphocytosis
Target Organs Eyes, skin, respiratory system
See also: INTRODUCTION